Table 3.
Multivariate analysis: odds ratio for prevalent high-risk human papillomavirus (HR-PV) among all FSWs.
| Bacterial vaginosis | Trichomonas vaginalis | Candida spp. | ||||
|---|---|---|---|---|---|---|
| OR | 95% confidence interval | OR | 95% confidence interval | OR | 95% confidence interval | |
| HPV 16 | 0.117 | 0.038–0.359 | — | — | — | — |
| HPV 18 | — | — | 0.047 | 0.012–0.177 | 3.423 | 1.3227–8.829 |
| HPV 31 | 0.342 | 0.125–0.939 | — | — | — | — |
| HPV 33 | 0.179 | 0.062–0.512 | — | — | — | — |
| HPV 35 | 0.244 | 0.080–0.740 | — | — | — | — |
| HPV 39 | — | — | — | — | — | — |
| HPV 45 | — | — | 0.257 | 0.077–0.858 | — | — |
| HPV 51 | — | — | — | — | — | — |
| HPV 52 | 0.281 | 0.104–0.763 | — | — | — | — |
| HPV 56 | — | — | — | — | — | — |
| HPV 58 | — | — | — | — | — | — |
| HPV 59 | — | — | — | — | — | — |
| HPV 66 | — | — | 0.040 | 0.011–0.148 | — | — |
| HPV 68 | — | — | 4.968 | 1.353–18.250 | — | — |
We detect a significant effect of BV versus trichomoniasis on incident HR-HPV.